메뉴 건너뛰기
Dermatologic Therapy
Volumn 24, Issue 2, 2011, Pages 287-290
Abatacept: Our experience of use in two patients with refractory psoriasis and psoriatic arthritis
Author keywords

Abatacept; Psoriasis; Psoriatic arthritis
Indexed keywords

ABATACEPT; ETRETIN; METHOTREXATE; PREDNISONE; ANTIBODY CONJUGATE; DERMATOLOGICAL AGENT;
EID: 79952775772     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2011.01405.x     Document Type: Article
Times cited : (14)
References (6)
  • 1
    • 0033135564 scopus 로고    scopus 로고
    • CTLA4Igmediated blockade of T-cell costimulation in patients with psoriasis vulgaris
    • Abrams JR, Lebwohl MG, Guzzo CA, et al. CTLA4Igmediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest 1999: 103: 1243-1252.
    • (1999) J Clin Invest , vol.103 , pp. 1243-1252
    • Abrams, J.R.1    Lebwohl, M.G.2    Guzzo, C.A.3
  • 2
    • 0025830902 scopus 로고
    • CTLA-4 is a second receptor for the B-cell activation antigen B7
    • Linsley PS, et al. CTLA-4 is a second receptor for the B-cell activation antigen B7. J Exp Med 1991: 174: 561-569.
    • (1991) J Exp Med , vol.174 , pp. 561-569
    • Linsley, P.S.1
  • 3
    • 0027245516 scopus 로고
    • Expression and function of B7 on human epidermal Langerhans cells
    • Symington FW, Brady W, Linsley PS. Expression and function of B7 on human epidermal Langerhans cells. J Immunol 1993: 150: 1286-1295. (Pubitemid 23127418)
    • (1993) Journal of Immunology , vol.150 , Issue.4 , pp. 1286-1295
    • Symington, F.W.1    Brady, W.2    Linsley, P.S.3
  • 4
    • 41649096507 scopus 로고    scopus 로고
    • Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis
    • Massarotti EM. Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis. Clin Ther 2008: 30: 429-441.
    • (2008) Clin Ther , vol.30 , pp. 429-441
    • Massarotti, E.M.1
  • 5
    • 34247535331 scopus 로고    scopus 로고
    • Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: A medical revolution
    • DOI 10.1136/pgmj.2006.052688
    • Kuek A, Hazleman BL, Ostor AJK. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 2007: 83: 251-260. (Pubitemid 46663012)
    • (2007) Postgraduate Medical Journal , vol.83 , Issue.978 , pp. 251-260
    • Kuek, A.1    Hazleman, B.L.2    Ostor, A.J.K.3
  • 6
    • 0034605033 scopus 로고    scopus 로고
    • Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells
    • Abrams JR, Kelley SL, Hayes E, et al. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 2000: 192: 681-693.
    • (2000) J Exp Med , vol.192 , pp. 681-693
    • Abrams, J.R.1    Kelley, S.L.2    Hayes, E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.